Journals / Archives of Rheumatology / 2017 / Cilt: 32 - Sayı: 4

Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms

Pages
284–289
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Including sB2M in our conventional diagnostic arsenal may assist in the evaluation of patients in whom SS is suspected; however, further studies are needed to clarify this hypothesis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to describe salivary beta-2 microglobulin (sB2M) levels in our setting and to assess the performance of sB2M for the diagnosis of Sjögren's syndrome (SS).Patients and methods: This cross-sectional, comparative study included 192 SS patients (2 males, 190 females; mean age 53.1 years; range 23 to 84 years) and 64 healthy controls (1 male, 63 females; mean age 46.9 years; range 21 to 82 years).
📊
Key Findings & Data:Patients were divided into three groups as those with primary SS, secondary SS, and sicca non-Sjögren's syndrome (snSS). sB2M was measured by enzyme-linked immunosorbent assay in whole unstimulated saliva (ng/mL).
💡
Conclusion & Impact:Including sB2M in our conventional diagnostic arsenal may assist in the evaluation of patients in whom SS is suspected; however, further studies are needed to clarify this hypothesis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to describe salivary beta-2 microglobulin (sB2M) levels in our setting and to assess the performance of sB2M for the diagnosis of Sjögren's syndrome (SS).Patients and methods: This cross-sectional, comparative study included 192 SS patients (2 males, 190 females; mean age 53.1 years; range 23 to 84 years) and 64 healthy controls (1 male, 63 females; mean age 46.9 years; range 21 to 82 years). Patients were divided into three groups as those with primary SS, secondary SS, and sicca non-Sjögren's syndrome (snSS). sB2M was measured by enzyme-linked immunosorbent assay in whole unstimulated saliva (ng/mL). Differences in sB2M were evaluated using the Kruskal-Wallis test. Receiver operating curves were generated to determine the performance of sB2M for distinguishing between SS and non-autoimmune snSS groups, and between SS group and healthy controls.Results: The primary SS and secondary SS groups had a significantly higher concentration of sB2M than the other two groups. There was no significant difference in the concentration of sB2M between primary SS and secondary SS groups, and neither between snSS group and healthy controls. The receiver operating curve analysis for distinguishing SS and snSS showed an area under the curve of 0.661 (95% confidence interval 0.590-0.728, p=0.0001) with an optimal cutoff value of 0.582 ng/mL. Sensitivity, specificity, positive predictive value, and negative predictive value were 68.7%, 59.3%, 20.2%, and 92.7%, respectively. The reported prevalence of SS in Mexico was considered when calculating the last two values.Conclusion: In our setting, sB2M effectively distinguished between SS patients and non-autoimmune sicca symptoms. Including sB2M in our conventional diagnostic arsenal may assist in the evaluation of patients in whom SS is suspected; however, further studies are needed to clarify this hypothesis.

🔖

Cite This Article

TORRES, J. R., TAYLOR, C. S., NORİEGA, C. M. S. (2022). Beta-2 Microglobulin in Whole Unstimulated Saliva Can Effectively Distinguish Between Sjögren's Syndrome and Non-Autoimmune Sicca Symptoms. Archives of Rheumatology, Cilt: 32 - Sayı: 4, 284–289. https://ajindex.com/articles/448036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Talal N, Grey HM, Zvaifler N, Michalski JP, Daniels TE. Elevated salivary and synovial fluid beta2- microglobulin in Sjogren's syndrome and rheumatoid arthritis. Science 1975;187:1196-8
  2. Baldini C, Gallo A, Perez P, Mosca M, Alevizos I, Bombardieri S. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. Clin Exp Rheumatol 2012;30:785-90
  3. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006;45:1077-86
  4. Castro J, Jiménez-Alonso J, Sabio JM, Rivera-Cívico F, Martín-Armada M, Rodríguez MA, et al. Salivary and serum beta2-microglobulin and gamma-glutamyltransferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta 2003;334:225-31
  5. Asashima H, Inokuma S, Onoda M, Oritsu M. Cutoff levels of salivary beta2-microglobulin and sodium differentiating patients with Sjögren's syndrome from those without it and healthy controls. Clin Exp Rheumatol 2013;31:699-703
  6. Goules AV, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren's syndrome. J Autoimmun 2014;48-49:42-5
  7. Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E. Diagnosis and classification of rheumatoid arthritis. J Autoimmun 2014;48-49:26-30
  8. Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 2014;48-49:10-3
  9. Häuser W, Wolfe F. Diagnosis and diagnostic tests for fibromyalgia (syndrome). Reumatismo 2012;64:194-205
  10. Garza-García F, Delgado-García G, Garza-Elizondo M, Ceceñas-Falcón LÁ, Galarza-Delgado D, Riega-Torres J. Salivary b2-microglobulin positively correlates with ESSPRI in patients with primary Sjögren's syndrome. Rev Bras Reumatol Engl Ed 2017;57:182-184
  11. Conover W. Practical Nonparametric Statistics. 3rd ed. New York: John Wiley & Sons; 1999
  12. Sánchez-Guerrero J, Pérez-Dosal MR, CárdenasVelázquez F, Pérez-Reguera A, Celis-Aguilar E, SotoRojas AE, et al. Prevalence of Sjögren's syndrome in ambulatory patients according to the AmericanEuropean Consensus Group criteria. Rheumatology (Oxford) 2005;44:235-40
  13. Kirkman T. Statistics to Use [Internet]. 1996 Available from: http://www.physics.csbsju.edu/stats/ [Access: May 30, 2016]
  14. Maddali Bongi S, Campana G, D'Aga